Name | Position | Professional Background |
Park Soyeon | Executive Director | Former: Advisor, Singapore National Institute of Science and Technology (A*STAR) |
CEO | Former: Director, KIT-ISIS Bio Drug Development Research Centre | |
Chairman of the BOD | Former: Director, Prestige Biologics (Korea) | |
Current: CEO, Prestige Biopharma (Singapore) |
Kim Michael Jinwoo | Executive Director | Former: Consultant, Peat Marwick Mclintok, USA (formerly KPMG) |
COO | Former: Managing Director, QION Pte Ltd (Singapore) | |
Former: Director, Prestige Biologics (Korea) | ||
Current: Director/COO, Prestige Biopharma (Singapore) |
Tay Lai Wat | Executive Director | Former: COO&CFO, Stamford Land Group (Singapore) |
Current: Real Estate Consultant and Investment Director, Octava QMBP Pty Ltd (Australia) | ||
Current: Director, Prestige Biopharma (Singapore) |
Oh Seung Joo | Non-executive Director | Former: M&A Consultant, Samjung Accounting Firm |
Current: Head of PE Department, KB Securities | ||
Current: Non-executive Director |
Bang Kue Ho | Non-executive Director | Former: Head of Biopharmaceutical Production Center, Osong Advanced Medical Industry Promotion Foundation |
Current: Professor of Pharmaceutical Engineering, Kyungnam University of Science and technology | ||
Current: Director, Prestige Biopharma (Singapore) |
Lee Eui Kyung | Independent Director | Former: Editorial member and Executive Director, Korean Financial Management Association |
Current: Professor of Business Administration, Daejin University | ||
Current: Independent Director, Prestige Biopharma (Singapore) |
Lee Kok Fatt | Independent Director | Former: Director, United Overseas Bank Limited (Singapore) |
Current: General Manager, Gardens by the Bay (Singapore) | ||
Current: Independent Director, Prestige Biopharma (Singapore) |
Jeon Kyunghee | Independent Director | Current: Director, Surim Cultural Foundation |
Current: Attorney of Daejeon Ajou Law Firm | ||
Current: Independent Director, Prestige Biopharma (Singapore) |